Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up

BACKGROUND AND PURPOSE: There are only limited studies on perampanel (PER), one of the latest antiepileptic drug. This study aimed to evaluate the long-term efficacy and tolerability of perampanel as an add-on therapy in patients with intractable focal epilepsy. METHODS: The medical records of 97 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo Yeon, Kim, Woo Joong, Kim, Hyuna, Choi, Sun Ah, Lim, Byung Chan, Chae, Jong-Hee, Kim, Ki Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374530/
https://www.ncbi.nlm.nih.gov/pubmed/30809498
http://dx.doi.org/10.14581/jer.18010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374530/
https://www.ncbi.nlm.nih.gov/pubmed/30809498
http://dx.doi.org/10.14581/jer.18010

Ejemplares similares